33043-37-7

Basic information

• Product Name: (R)-N-ACETYL-3,4-DIMETHOXYPHENYLALANINE
• Synonyms: (R)-N-ACETYL-3,4-DIMETHOXYPHENYLALANINE;N-ACETYL-3-(3,4-DIMETHOXYPHENYL)-D-ALANINE
• CAS NO: 33043-37-7
• Molecular Formula: C₁₃H₁₇NO₅
• Molecular Weight: 267.28
• Mol File: 33043-37-7.mol
• Article Data: 5

Chemical Properties

• Melting Point: 150-152 °C(lit.)
• Boiling Point: 502.5 °C at 760 mmHg
• Flash Point: 257.7 °C
• Appearance: /
• Density: 1.21 g/cm³
• CAS DataBase Reference: (R)-N-ACETYL-3,4-DIMETHOXYPHENYLALANINE(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-N-ACETYL-3,4-DIMETHOXYPHENYLALANINE(33043-37-7)
• EPA Substance Registry System: (R)-N-ACETYL-3,4-DIMETHOXYPHENYLALANINE(33043-37-7)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 36/37/38-22
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 33043-37-7(Hazardous Substances Data)

Usage

General Description

(R)-N-ACETYL-3,4-DIMETHOXYPHENYLALANINE is a chemical compound with a molecular formula C13H17NO5. It is a derivative of the amino acid phenylalanine and is commonly used in the research and development of pharmaceuticals and biotechnology. (R)-N-ACETYL-3,4-DIMETHOXYPHENYLALANINE is known for its potential therapeutic applications, including its role as an inhibitor of enzymes involved in the biosynthesis of neurotransmitters, making it a potential target for the treatment of neurological disorders. Additionally, (R)-N-ACETYL-3,4-DIMETHOXYPHENYLALANINE has also been studied for its anti-inflammatory and antioxidant properties, making it a versatile compound with potential uses in the fields of medicine and drug development.

Upstream product

• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 41888-65-7 4-(3,4-dimethoxybenzylidene)-2-methyloxazol-5(4H)-one 
• 38879-47-9 (Z)-4-(3,4-dimethoxybenzylidene)-2-methyl-5(4H)-oxazolone 
• 76313-28-5 2-acetylamino-3-(3,4-dimethoxy-1-phenyl)-2-propenoic acid 

Relevant articles and documents

Asymmetric synthesis of unnatural amino acids and tamsulosin chiral intermediate

An efficient and enantioselective hydrogenation of N-acetylamino phenyl acrylic acids was successfully developed by using ruthenium catalyst. This methodology is important in the field of pharmaceuticals and provides a new process for the preparation of unnatural amino acids and tamsulosin chiral intermediate.

Enantioselektivitaetssteigerung bei asymmetrischen Hydrierungen in Wasser unter dem Einfluss von Tensiden oder polymerisierten Micellen

-

Optically Pure (S)-6,7-dimethoxy-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid and asymmetric hydrogenation studies related to its preparation

-